# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-22-028197
Filing Date
2022-08-04
Accepted
2022-08-04 16:10:27
Documents
12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | ny20004078x20_424b3.htm | 424B3 | 6660386
2 |  | logo_centerviewpartnersv2.jpg | GRAPHIC | 20936
3 |  | logo_eq.jpg | GRAPHIC | 19579
4 |  | logo_georgeson2.jpg | GRAPHIC | 27678
5 |  | ny20004078x20_flowchart01.jpg | GRAPHIC | 74519
6 |  | ny20004078x20_flowchart02.jpg | GRAPHIC | 119546
7 |  | ny20004078x20_flowchart03.jpg | GRAPHIC | 128125
8 |  | ny20004078x20_flowchartx1.jpg | GRAPHIC | 64922
9 |  | ny20004078x20_flowchartx2.jpg | GRAPHIC | 104888
10 |  | ny20004078x20_flowchartx3.jpg | GRAPHIC | 108201
11 |  | ny20004078x20_piechart01.jpg | GRAPHIC | 62309
12 |  | ny20004078x20_piechart02.jpg | GRAPHIC | 47804
| Complete submission text file | 0001140361-22-028197.txt |  | 7731585

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 424B3 | Act: 33 | File No.: 333-263667 | Film No.: 221136635
SIC: 2835 In Vitro & In Vivo Diagnostic Substances